{"text": ["Pharma", "Stock", "Roundup:", "Mixed", "Q1", "for", "MRK,", "PFE,", "FDA", "Nod", "for", "Kymriah's", "2nd", "Indication"], "created_at": "2018-05-04 22:07:49"}
{"text": ["Pharma", "Stock", "Roundup:", "Mixed", "Q1", "for", "MRK,", "PFE,", "FDA", "Nod", "for", "Kymriah's", "2nd", "Indication"], "created_at": "2018-05-04 22:07:49"}
{"text": ["Pharma", "Stock", "Roundup:", "Mixed", "Q1", "for", "MRK,", "PFE,", "FDA", "Nod", "for", "Kymriah&apos;s", "2nd", "Indication"], "created_at": "2018-05-04 20:06:08"}
{"text": ["Aduro", "(ADRO)", "Q1", "Loss", "Narrower", "Than", "Expected,", "Revenues", "Beat"], "created_at": "2018-05-04 18:07:54"}
{"text": ["Aduro", "(ADRO)", "Q1", "Loss", "Narrower", "Than", "Expected,", "Revenues", "Beat"], "created_at": "2018-05-04 18:07:54"}
{"text": ["FDA", "approves", "Novartis", "combo", "therapy", "for", "aggressive", "type", "of", "thyroid", "cancer"], "created_at": "2018-05-04 17:06:02"}
{"text": ["Prolia", "Revenue", "Grew", "16%", "in", "1Q18"], "created_at": "2018-05-04 15:15:11"}
{"text": ["3", "\u201cHigh", "Yield", "Leaders\u201d", "to", "Buy", "for", "5%", "to", "12%", "Payouts"], "created_at": "2018-05-04 15:11:30"}
{"text": ["3", "\u201cHigh", "Yield", "Leaders\u201d", "to", "Buy", "for", "5%", "to", "12%", "Payouts"], "created_at": "2018-05-04 15:11:30"}
{"text": ["Kyprolis", "Is", "Expected", "to", "Boost", "Amgen\u2019s", "Revenue", "Growth"], "created_at": "2018-05-04 13:45:11"}
{"text": ["The", "Swiss", "Stock", "Market"], "created_at": "2018-05-04 12:20:00"}
{"text": ["The", "Swiss", "Stock", "Market"], "created_at": "2018-05-04 12:20:00"}
